Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy - Chen, Xin; Heller, Martina; Nientiedt, Cathleen; Falkenstein, Michael; Herpel, Esther; Jenzer, Maximilian; Grüllich, Carsten; Jäger, Dirk; Hohenfellner, Markus; Duensing, Stefan; Sültmann, Holger; Debus, Jürgen (Urologic oncology, 2018)
Gesehen am 02.07.2018